EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors

Lianlian Du iD, Bruce P Hermann iD, Erin M Jonaitis, Karly Alex Cody iD, Leonardo Rivera-Rivera iD, Howard Rowley, Aaron Field, Laura Eisenmenger, Bradley T Christian, Tobey J Betthauser iD, Bret Larget, Rick Chappell and 4 more

Brain Communications · 2023-11-01 · 5 (6)

DOI: 10.1093/braincomms/fcad333 ↗

At a glance

Journal article in Brain Communications, published online on 2023-12-03. Written by Lianlian Du and 15 co-authors. Institution: Wisconsin Alzheimer's Institute, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53792, USA. Cited 14 times so far (Crossref); 86 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Institute on Aging.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cognitive decline in Alzheimer’s disease and other dementias typically begins long before clinical impairment. Identifying people experiencing subclinical decline may facilitate earlier intervention. This study developed cognitive trajectory clusters using longitudinally based random slope and change point parameter estimates from a Preclinical Alzheimer’s disease Cognitive Composite and examined how baseline and most recently available clinical/health-related characteristics, cognitive statuses and biomarkers for Alzheimer’s disease and vascular disease varied across these cognitive clusters. Data were drawn from the Wisconsin Registry for Alzheimer’s Prevention, a longitudinal cohort study of adults from late midlife, enriched for a parental history of Alzheimer’s disease and without dementia at baseline. Participants who were cognitively unimpaired at the baseline visit with ≥3 cognitive visits were included in trajectory modelling (n = 1068). The following biomarker data were available for subsets: positron emission tomography amyloid (amyloid: n = 367; [11C]Pittsburgh compound B (PiB): global PiB distribution volume ratio); positron emission tomography tau (tau: n = 321; [18F]MK-6240: primary regions of interest meta-temporal composite); MRI neurodegeneration (neurodegeneration: n = 581; hippocampal volume and global brain atrophy); T2 fluid-attenuated inversion recovery MRI white matter ischaemic lesion volumes (vascular: white matter hyperintensities; n = 419); and plasma pTau217 (n = 165). Posterior median estimate person-level change points, slopes’ pre- and post-change point and estimated outcome (intercepts) at change point for cognitive composite were extracted from Bayesian Bent-Line Regression modelling and used to characterize cognitive trajectory groups (K-means clustering). A common method was used to identify amyloid/tau/neurodegeneration/vascular biomarker thresholds. We compared demographics, last visit cognitive status, health-related factors and amyloid/tau/neurodegeneration/vascular biomarkers across the cognitive groups using ANOVA, Kruskal–Wallis, χ2, and Fisher’s exact tests. Mean (standard deviation) baseline and last cognitive assessment ages were 58.4 (6.4) and 66.6 (6.6) years, respectively. Cluster analysis identified three cognitive trajectory groups representing steep, n = 77 (7.2%); intermediate, n = 446 (41.8%); and minimal, n = 545 (51.0%) cognitive decline. The steep decline group was older, had more females, APOE e4 carriers and mild cognitive impairment/dementia at last visit; it also showed worse self-reported general health-related and vascular risk factors and higher amyloid, tau, neurodegeneration and white matter hyperintensity positive proportions at last visit. Subtle cognitive decline was consistently evident in the steep decline group and was associated with generally worse health. In addition, cognitive trajectory groups differed on aetiology-informative biomarkers and risk factors, suggesting an intimate link between preclinical cognitive patterns and amyloid/tau/neurodegeneration/vascular biomarker differences in late middle-aged adults. The result explains some of the heterogeneity in cognitive performance within cognitively unimpaired late middle-aged adults.

Subjects

Author keywords

amyloidchange pointneurodegenerationpreclinical trajectoriesvascular

Authors and institutions

  • Wisconsin Alzheimer's Institute, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53792, USA.
  • Wisconsin Alzheimer's Disease Research Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53792, USA.
  • Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53792, USA.
  • Department of Neurology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53705, USA.
  • Department of Medical Physics, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53705, USA.
  • Department of Radiology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI 53792, USA.

ORCID profiles: Lianlian Du, Bruce P Hermann, Karly Alex Cody, Leonardo Rivera-Rivera, Tobey J Betthauser, Oskar Hansson, Rebecca Langhough

Funding

  • National Institute on Aging

Cite

APA

Du, L., Hermann, B. P., Jonaitis, E. M., Cody, K. A., Rivera-Rivera, L., Rowley, H., Field, A., Eisenmenger, L., Christian, B. T., Betthauser, T. J., Larget, B., Chappell, R., Janelidze, S., Hansson, O., Johnson, S. C., & Langhough, R. (2023). Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors. Brain Communications, 5(6). https://doi.org/10.1093/braincomms/fcad333

Vancouver

Du L, Hermann BP, Jonaitis EM, Cody KA, Rivera-Rivera L, Rowley H, et al. Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors. Brain Communications. 2023;5(6). doi:10.1093/braincomms/fcad333

BibTeX
@article{Du2023,
  author = {Du, Lianlian and Hermann, Bruce P and Jonaitis, Erin M and Cody, Karly Alex and Rivera-Rivera, Leonardo and Rowley, Howard and Field, Aaron and Eisenmenger, Laura and Christian, Bradley T and Betthauser, Tobey J and Larget, Bret and Chappell, Rick and Janelidze, Shorena and Hansson, Oskar and Johnson, Sterling C and Langhough, Rebecca},
  title = {Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors},
  journal = {Brain Communications},
  year = {2023},
  volume = {5},
  number = {6},
  doi = {10.1093/braincomms/fcad333}
}
Start for free →